ConductScience.org, home

Trial · NCT02683239

Adverse events3,192

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherArthralgiaMusculoskeletal and connective tissue disordersFasinumab-matching Placebo Q4W/Q8W4131,257771
otherArthralgiaMusculoskeletal and connective tissue disordersFasinumab 1mg SC Q8W347966636
otherArthralgiaMusculoskeletal and connective tissue disordersFasinumab 1mg SC Q4W350974633
otherArthralgiaMusculoskeletal and connective tissue disordersFasinumab 3mg SC Q4W69214109
otherArthralgiaMusculoskeletal and connective tissue disordersFasinumab 6mg SC Q8W7101,6771,358
otherArthralgiaMusculoskeletal and connective tissue disordersFasinumab 6mg SC Q4W53116115
otherArthralgiaMusculoskeletal and connective tissue disordersFasinumab 9mg SC Q4W4511582
otherBack painMusculoskeletal and connective tissue disordersFasinumab-matching Placebo Q4W/Q8W2041,257363
otherBack painMusculoskeletal and connective tissue disordersFasinumab 1mg SC Q8W207966336
otherBack painMusculoskeletal and connective tissue disordersFasinumab 1mg SC Q4W185974301
otherBack painMusculoskeletal and connective tissue disordersFasinumab 3mg SC Q4W3021437
otherBack painMusculoskeletal and connective tissue disordersFasinumab 6mg SC Q8W2831,677519
otherBack painMusculoskeletal and connective tissue disordersFasinumab 6mg SC Q4W1411624
otherBack painMusculoskeletal and connective tissue disordersFasinumab 9mg SC Q4W1311518
otherPain in extremityMusculoskeletal and connective tissue disordersFasinumab-matching Placebo Q4W/Q8W1131,257151
otherPain in extremityMusculoskeletal and connective tissue disordersFasinumab 1mg SC Q8W114966144
otherPain in extremityMusculoskeletal and connective tissue disordersFasinumab 1mg SC Q4W124974181
otherPain in extremityMusculoskeletal and connective tissue disordersFasinumab 3mg SC Q4W1621431
otherPain in extremityMusculoskeletal and connective tissue disordersFasinumab 6mg SC Q8W1511,677215
otherPain in extremityMusculoskeletal and connective tissue disordersFasinumab 6mg SC Q4W2011629

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02683239/events